Grenada vs Sao Tome and Principe: The number of people with susceptibility test result for rifampicin
Grenada
0
in 2021
Sao Tome and Principe
0
in 2021
Grenada rank
142nd
Sao Tome and Principe rank
142nd
The number of people with susceptibility test result for rifampicin over time
- Grenada
- Sao Tome and Principe
How they compare
Grenada currently reports 0 against 0 in Sao Tome and Principe, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Sao Tome and Principe ahead.
Grenada ranks 142nd and Sao Tome and Principe ranks 142nd of 146 countries.
Across the 2 decades both report, Grenada averaged higher in 1 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Grenada | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 33.33 | 20.76 | 12.57 | Grenada |
| 2020s | 0 | 1.04 | 1.04 | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Grenada or Sao Tome and Principe?
- Grenada, at 0 against 0 in Sao Tome and Principe as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Grenada and Sao Tome and Principe?
- 0, with Grenada ahead.
- How many years of comparable data are there for Grenada and Sao Tome and Principe?
- 5 years are reported by both, from 2017 to 2021.
- How do Grenada and Sao Tome and Principe rank globally for the number of people with susceptibility test result for rifampicin?
- Grenada ranks 142nd and Sao Tome and Principe ranks 142nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.